These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27825347)

  • 1. Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients.
    Milara J; Cervera A; de Diego A; Sanz C; Juan G; Gavaldà A; Miralpeix M; Morcillo E; Cortijo J
    Respir Res; 2016 Nov; 17(1):145. PubMed ID: 27825347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients.
    Milara J; Contreras S; de Diego A; Calbet M; Aparici M; Morcillo E; Miralpeix M; Cortijo J
    PLoS One; 2019; 14(1):e0210188. PubMed ID: 30608978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease.
    Milara J; Lluch J; Almudever P; Freire J; Xiaozhong Q; Cortijo J
    J Allergy Clin Immunol; 2014 Aug; 134(2):314-22. PubMed ID: 24636089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
    Malerba M; Radaeli A; Santini G; Morjaria J; Mores N; Mondino C; Macis G; Montuschi P
    Expert Opin Drug Discov; 2018 Jun; 13(6):563-577. PubMed ID: 29616842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aclidinium bromide combined with formoterol inhibits remodeling parameters in lung epithelial cells through cAMP.
    Lambers C; Costa L; Ying Q; Zhong J; Lardinois D; Dekan G; Schuller E; Roth M
    Pharmacol Res; 2015 Dec; 102():310-8. PubMed ID: 26546746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?
    Blasi F; Canonica GW; Miravitlles M
    Respir Res; 2017 Jan; 18(1):19. PubMed ID: 28100244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Long-Acting Beta
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.
    Maltais F; Milot J
    Ther Adv Respir Dis; 2012 Dec; 6(6):345-61. PubMed ID: 23075544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of granulocyte migration by tiotropium bromide.
    Vacca G; Randerath WJ; Gillissen A
    Respir Res; 2011 Feb; 12(1):24. PubMed ID: 21352583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β₂ long-acting and anticholinergic drugs control TGF-β1-mediated neutrophilic inflammation in COPD.
    Profita M; Bonanno A; Montalbano AM; Albano GD; Riccobono L; Siena L; Ferraro M; Casarosa P; Pieper MP; Gjomarkaj M
    Biochim Biophys Acta; 2012 Jul; 1822(7):1079-89. PubMed ID: 22440430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Joos GF
    Expert Opin Investig Drugs; 2010 Feb; 19(2):257-64. PubMed ID: 20047505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside.
    Cazzola M; Calzetta L; Ora J; Puxeddu E; Rogliani P; Matera MG
    Respir Med; 2015 Oct; 109(10):1305-11. PubMed ID: 26303336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of YKL-40 expression by corticosteroids: effect on pro-inflammatory macrophages in vitro and its modulation in COPD in vivo.
    Kunz LI; van't Wout EF; van Schadewijk A; Postma DS; Kerstjens HA; Sterk PJ; Hiemstra PS
    Respir Res; 2015 Dec; 16():154. PubMed ID: 26696093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide.
    Gavaldà A; Ramos I; Carcasona C; Calama E; Otal R; Montero JL; Sentellas S; Aparici M; Vilella D; Alberti J; Beleta J; Miralpeix M
    Pulm Pharmacol Ther; 2014 Aug; 28(2):114-21. PubMed ID: 24928173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aclidinium bromide in a cigarette smoke-exposed Guinea pig model of chronic obstructive pulmonary disease.
    Domínguez-Fandos D; Ferrer E; Puig-Pey R; Carreño C; Prats N; Aparici M; Musri MM; Gavaldà A; Peinado VI; Miralpeix M; Barberà JA
    Am J Respir Cell Mol Biol; 2014 Feb; 50(2):337-46. PubMed ID: 24032416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi.
    Cazzola M; Calzetta L; Page CP; Rogliani P; Facciolo F; Gavaldà A; Matera MG
    Eur J Pharmacol; 2014 Dec; 745():135-43. PubMed ID: 25446566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
    Gupta V; Singh D
    Expert Rev Respir Med; 2012 Dec; 6(6):581-8. PubMed ID: 23234445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled muscarinic acetylcholine receptor antagonists for treatment of COPD.
    Montuschi P; Macagno F; Valente S; Fuso L
    Curr Med Chem; 2013; 20(12):1464-76. PubMed ID: 22963553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Rogliani P; Matera MG
    Expert Opin Pharmacother; 2013 Apr; 14(6):775-81. PubMed ID: 23472632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease.
    Milara J; Díaz-Platas L; Contreras S; Ribera P; Roger I; Ballester B; Montero P; Cogolludo Á; Morcillo E; Cortijo J
    Respir Res; 2018 Nov; 19(1):226. PubMed ID: 30458870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.